Chapter 53
Constriction of Ductus Arteriosus by Selective Inhibition of Cyclooxygenase-1 and -2
Katsuaki Toyoshima,
Atsuhito Takeda,
Shinichiro Imamura,
Kazuo Momma,
Katsuaki Toyoshima
Search for more papers by this authorAtsuhito Takeda
Search for more papers by this authorShinichiro Imamura
Search for more papers by this authorKazuo Momma
Search for more papers by this authorKatsuaki Toyoshima,
Atsuhito Takeda,
Shinichiro Imamura,
Kazuo Momma,
Katsuaki Toyoshima
Search for more papers by this authorAtsuhito Takeda
Search for more papers by this authorShinichiro Imamura
Search for more papers by this authorKazuo Momma
Search for more papers by this authorBook Editor(s):Michael Artman MD, D. Woodrow Benson MD, PhD,
Deepak Srivastava MD,
Makoto Nakazawa MD,
D. Woodrow Benson MD, PhD
Professor of Pediatrics, Director, Cardiovascular Genetics, Division of Cardiology, Cincinnati Children's Hospital Medical Center
Search for more papers by this authorDeepak Srivastava MD
Pogue Distinguished Chair in Research on Cardiac Birth Defects, Joel B. Steinberg, M.D. Chair in Pediatrics Professor, Departments of Pediatrics and Molecular Biology, University of Texas, Southwestern Medical Center at Dallas
Search for more papers by this authorMakoto Nakazawa MD
Professor and Head, Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University
Search for more papers by this authorFirst published: 01 January 2005
Summary
This chapter contains sections titled:
-
Methods
References
- Heymann MA, Rudolph AM. Control of the ductus arteriosus. Physiol Rev 1975; 55: 62–78.
- Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 1973; 51: 220–5.
- Momma K, Uemura S, Nishihara S, et al. Dilatation of the ductus arteriosus by prostaglandins and prostaglandin's precursor. Pediatr Res 1980; 14: 1074–7.
- Vane JR, Botting RM. Mechanism of action of nonsteroidal antiinflammatory drugs. Am J Med 1998; 104: 2S–8S.
- Warner TD, Giuliano F, Vane JR, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci USA 1999; 96: 7563–8.
- Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998; 95: 13313–18.
- Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by nonsteroidal antiinflammatory drug. Prostaglandins 1983; 26: 631–43.
- Momma K, Hagiwara H, Konishi T. Constriction of fetal ductus arteriosus by nonsteroidal antiinflammatory drug: study of additional 34 drugs. Prostaglandins 1984; 28 : 527–36.
- Guerguerian AM, Hardy P, Clyman RI, et al. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am J Obstet Gynecol 1998; 179: 1618–26.
- Clyman RI, Hardy P, Waleh N, et al. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus. Am J Physiol 1999; 276: R913-21.
- Takahashi Y, Roman C, Chomtob S, et al. Cyclooxygenase-2 inhibitors constricts the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regulatory Integrative Comp Physiol 2000; 278: R1496-505.
- Coceani F, Ackerley C, Seidlitz E, et al. Function of cyclo-oxygenase-1 and cyclooxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin. Br J Pharmacol 2001; 132: 241–51.
- Slater DM, Berger LC, Newton R, et al. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol 1995; 172: 77–82.
- Slater DM, Berger LC, Newton R, et al. Expression of cyclooxygenase types 1 and 2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999; 22: 125–30.
- Sawdy RJ, Slater DM, Dennes WJB, et al. The roles of the cyclooxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000; 21 : 54–7.
- Momma K, Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999; 46: 311–15.
